Michael Burke MD in Bradenton, Florida

Additional Medical Specialties Include:
CRITICAL CARE (INTENSIVISTS), INTERNAL MEDICINE

Medical School: University Of South Alabama College Of Medicine
Graduation Year: 2004
The Primary Medical Specialty for Michael Burke MD is listed as: Pulmonary Disease
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 20
PAC (PECOS ID)#: 3375548613
NPI #: 1043236557
NPI Created On: 07/15/2006
NPI Last Updated Listed as: 01/07/2022
Primary Taxonomy Code: 207RC0200X
License Number:
ME111430
Listed Gender: Male

Forms of insurance accepted by include, but are not limited to:

• Humana
• Blue Cross Blue Shield
• Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

Services and Procedures include:

1. Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration
2. Demonstration and/or evaluation of patient use of aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure breathing (ippb) device
3. Determination of lung volumes using gas dilution or washout
4. Measurement of lung diffusing capacity
5. Unattended sleep study with recording of heart rate, oxygen, respiratory airflow and effort
6. Sleep monitoring of patient (6 years or older) in sleep lab
7. Sleep monitoring of patient (6 years or older) in sleep lab with continued pressured respiratory assistance by mask or breathing tube
8. Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
9. New patient office or other outpatient visit, typically 45 minutes
10. New patient office or other outpatient visit, typically 60 minutes
11. Established patient office or other outpatient, visit typically 25 minutes
12. Established patient office or other outpatient, visit typically 40 minutes
13. Critical care delivery critically ill or injured patient, first 30-74 minutes
14. Smoking and tobacco use intermediate counseling, greater than 3 minutes up to 10 minutes
15. Injection, methylprednisolone acetate, 40 mg
16. Injection, dexamethasone sodium phosphate, 1 mg